been kinda nice not having the bashers popping up on the SGYP board.
as there is no board to bash on. Will say that Red Acre values at ROCK BOTTOM the pps of SGYP to be 6.50 and that given a 75% chance of approval of Plecanatide going forward they value the stock at a present PPS of 8.50......that's without having taken into account the better financial position SGYP is now in and their 100% ownership of the drug. When SGYP partners, it'll be a much better faring for SGYP that IRWD ended up with...and then there's the pipeline of SGYP's that will be a big time driver in the future as well.
As backup to my prognostication for the future...Cantor Fitzgerald has a upgrade and $10 share price for IRWD.....BUT...has raised their estimate to $15 from $12 at SGYP...what does that tell you. IT'll be awhile yet is the good thing I can say to IRWD shareholders.